Department of Health and Human Services

Part 1. Overview Information

Participating Organization(s)

National Institutes of Health (NIH)

Components of Participating Organizations

National Institute of Mental Health (NIMH)

National Eye Institute (NEI)

National Institute on Aging (NIA)

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

National Institute of Biomedical Imaging and Bioengineering (NIBIB)

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

National Institute on Deafness and Other Communication Disorders (NIDCD)

National Institute on Drug Abuse (NIDA)

National Institute of Neurological Disorders and Stroke (NINDS)

National Center for Complementary and Integrative Health (NCCIH)

All applications to this funding opportunity announcement should fall within the mission of the Institutes/Centers. The following NIH Offices may co-fund applications assigned to those Institutes/Centers.

Office of Behavioral and Social Sciences Research (OBSSR)

Funding Opportunity Title
BRAIN Initiative Fellows: Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (F32)
Activity Code

F32 Postdoctoral Individual National Research Service Award

Announcement Type
Reissue of RFA-MH-20-620
Related Notices

See Notices of Special Interest associated with this funding opportunity

January 4, 2024 - NIDCD Individual Fellowship Pre-Application Information Session. See Notice NOT-DC-24-013

NOT-OD-22-189 - Implementation Details for the NIH Data Management and Sharing Policy

NOT-OD-22-195 - New NIH "FORMS-H" Grant Application Forms and Instructions Coming for Due Dates on or after January 25, 2023

NOT-OD-22-198 - Implementation Changes for Genomic Data Sharing Plans Included with Applications Due on or after January 25, 2023

NOT-OD-23-012 - Reminder: FORMS-H Grant Application Forms & Instructions Must be Used for Due Dates On or After January 25, 2023 - New Grant Application Instructions Now Available

Funding Opportunity Announcement (FOA) Number
RFA-MH-23-110
Companion Funding Opportunity
None
Number of Applications

See Section III. 3. Additional Information on Eligibility.

Assistance Listing Number(s)
93.242, 93.273, 93.866, 93.867, 93.853, 93.279, 93.286, 93.173, 93.213, 93.865
Funding Opportunity Purpose

The purpose of the Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative Fellows (F32) program is to enhance the research training of promising postdoctorates early in their postdoctoral training period, who have the potential to become productive investigators in research areas that will advance the goals of the BRAIN Initiative. Applications are encouraged in any research area aligned with the BRAIN Initiative, including neuroethics. Applicants are expected to propose research training in an area that clearly complements their predoctoral research. Formal training in analytical tools appropriate for the proposed research is expected to be an integral component of the research training plan. In order to maximize the training potential of the F32 award, this program encourages applications from individuals who have not yet completed their terminal doctoral degree and expect to do so within 12 months of the application due date. On the application due date, candidates may not have completed more than 12 months of postdoctoral training.

This Funding Opportunity Announcement (FOA) does not allow applicants to propose to lead an independent clinical trial, but does allow applicants to propose research experience in a clinical trial led by a sponsor or co-sponsor.

Key Dates

Posted Date
March 31, 2023
Open Date (Earliest Submission Date)
July 09, 2023
Letter of Intent Due Date(s)

30 days prior to the application due date

Application Due Dates Review and Award Cycles
New Renewal / Resubmission / Revision (as allowed) AIDS Scientific Merit Review Advisory Council Review Earliest Start Date
August 09, 2023 August 09, 2023 Not Applicable November 2023 January 2024 April 2024
April 09, 2024 April 09, 2024 Not Applicable July 2024 October 2024 December 2024
December 10, 2024 December 10, 2024 Not Applicable March 2025 May 2025 July 2025
August 11, 2025 August 11, 2025 Not Applicable November 2025 January 2026 April 2026

All applications are due by 5:00 PM local time of applicant organization.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

Expiration Date
August 12, 2025
Due Dates for E.O. 12372

Not Applicable

Required Application Instructions

It is critical that applicants follow the Fellowship (F) instructions in the SF424 (R&R) Application Guide except where instructed to do otherwise (in this FOA or in a Notice from the NIH Guide for Grants and Contracts). Conformance to all requirements (both in the Application Guide and the FOA) is required and strictly enforced. Applicants must read and follow all application instructions in the Application Guide as well as any program-specific instructions noted in Section IV. When the program-specific instructions deviate from those in the Application Guide, follow the program-specific instructions. Applications that do not comply with these instructions may be delayed or not accepted for review.

There are several options available to submit your application through Grants.gov to NIH and Department of Health and Human Services partners. You must use one of these submission options to access the application forms for this opportunity.

  1. Use the NIH ASSIST system to prepare, submit and track your application online.
  2. Use an institutional system-to-system (S2S) solution to prepare and submit your application to Grants.gov and eRA Commons to track your application. Check with your institutional officials regarding availability.

  3. Use Grants.gov Workspace to prepare and submit your application and eRA Commons to track your application.


  4. Table of Contents

Part 2. Full Text of Announcement

Section I. Funding Opportunity Description

The overall goal of the NIH Ruth L. Kirschstein National Research Service Award (NRSA) program is to help ensure that a diverse pool of highly trained scientists is available in appropriate scientific disciplines to address the Nation's biomedical, behavioral, and clinical research needs. NRSA fellowships support the training of pre-and postdoctoral scientists, dual-degree investigators, and senior researchers. More information about NRSA programs may be found at the NIH Research Training and Career Development website.

The purpose of the Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (Parent F32) is to support promising candidates during their mentored postdoctoral training under the guidance of outstanding faculty sponsors. The integrated program of research and training should enhance the individual’s potential to develop into a productive, independent researcher. The research and training plans are expected to provide the candidate with a strong understanding of the rigorous research design, experimental methods, quantitative approaches, and data analysis. Applicants for the The Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative Fellows F32 program are expected to propose a research project and training plan in a scientific area relevant to one or more of the goals of the BRAIN Initiative, including neuroethics (see http://braininitiative.nih.gov). The integrated program of research and training is expected to provide applicants with training using cutting-edge tools, theories and/or approaches that will prepare them to launch independent research careers in areas that will advance the goals of the BRAIN Initiative. See the section, Specific Objectives of this FOA, below for details.

The BRAIN Initiative

Since 2014, the Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative has aimed to accelerate the development and application of innovative neurotechnologies, enabling researchers to produce a new dynamic picture of the brain that reveals how individual cells and complex neural circuits interact in both time and space. It is expected that these advances will ultimately lead to new ways to treat and prevent brain disorders.

As one of several federal agencies involved in the BRAIN Initiative, NIH's contributions to the BRAIN initiative were initially guided by "BRAIN 2025: A Scientific Vision," a strategic plan that detailed seven high-priority research areas. This plan was updated and enhanced in 2019 by: "The BRAIN Initiative 2.0: From Cells to Circuits, Toward Cures" and "The BRAIN Initiative and Neuroethics: Enabling and Enhancing Neuroscience Advances for Society." This and other BRAIN Initiative Funding Opportunity Announcements (FOAs) are based on this vision and issued with input from Advisory Councils of the10 NIH Institutes and Centers supporting the BRAIN Initiative, as assisted by the NIH BRAIN Multi-Council Working Group and Neuroethics Working Group.

In addition to the National BRAIN initiative, the NIH continues to have a substantial annual investment in neuroscience research and research training. The Institutes and Centers contributing to the NIH BRAIN Initiative (http://braininitiative.nih.gov/) support those research and research training efforts through investigator-initiated applications as well as through specific FOAs. Potential applicants to this FOA are strongly encouraged to contact Scientific/Program staff if they have any questions about the best FOA for their research training.

To enable rapid progress in the development of new technologies as well as in theory and data analysis, the BRAIN Initiative encourages collaborations between neurobiologists and researchers from statistics, physics, mathematics, engineering, and computer and information sciences; and NIH welcomes applications from investigators in these disciplines.

NIH encourages BRAIN Initiative applications from investigators from diverse backgrounds, including those who are underrepresented in the biomedical, behavioral, or clinical research workforce (see data posted by the National Science Foundation and the most recent report on Women, Minorities, and Persons with Disabilities in Science and Engineering), such as underrepresented racial and ethnic groups, those with disabilities, those from disadvantaged backgrounds, and women (see NOT-OD-20-031).

The BRAIN Initiative will require a high level of coordination and sharing between investigators. It is expected that BRAIN Initiative awardees will cooperate and coordinate their activities after awards are made by participating in annual BRAIN Initiative meetings and in other activities.

Education and Training to Advance the BRAIN Initiative

Educational goals for the NIH component of the BRAIN Initiative (see BRAIN 2025: A Scientific Vision) include the acquisition of quantitative skills, the appropriate use and integration of newly developed tools, technologies, and methods developed under the BRAIN Initiative, and consideration of the ethical implications of neuroscience research.

The BRAIN 2025 Report notes that individuals should obtain robust grounding in quantitative reasoning, principles, and techniques during their training. A special focus is training in quantitative neuroscience, i.e., theory and statistics for biologists, and exposing physicists, engineers, and statisticians to experimental neuroscience. The BRAIN 2025 and BRAIN Initiative 2.0 Reports strongly encourage investigators to cross traditional areas of expertise to conduct interdisciplinary research and acknowledge the need to attract investigators and faculty recruits to neuroscience from quantitative disciplines, e.g., statistics, computer science, physics, mathematics, and engineering.

The BRAIN 2025 Report emphasizes the need to consider the ethical implications of neuroscience research. In human neuroscience research, unique ethical issues are arising because new neurotechnologies are being employed that affect the human brain. In addition to grounding all neuroscience research training in consideration of ethical issues, it is necessary to invest in training individuals who will be the next generation of leaders in neuroethics research. For this reason, this FOA encourages applications from individuals interested in obtaining postdoctoral training on the ethical implications of recent advancements in neurotechnology and brain science that are relevant to the BRAIN initiative (see BRAIN Initiative RFA-MH-21-205).

This FOA is related to the education recommendations in Section II.7 of the BRAIN 2025 Report (http://www.nih.gov/science/brain/2025/index.htm). Specifically, this FOA solicits applications from early-stage postdoctorates to acquire mentored research training using cutting-edge tools, theories, and/or approaches in one of the seven high-priority areas of the BRAIN Initiative, including neuroethics. Given the expressed need to bring those trained in quantitative disciplines to neuroscience research, applications from individuals obtaining terminal doctorates in quantitative disciplines are encouraged.

For BRAIN Initiative awards to date, see http://www.braininitiative.nih.gov/funding/fundedAwards.htm.

Specific Objectives of this FOA

The integrated program of research and training supported by this FOA is intended for postdoctorates who are early in their postdoctoral training period in a given laboratory or research environment, rather than for advanced postdoctorates. Support for early postdoctoral training will maximize the training potential of this fellowship award. Given the interval when applications will be accepted (from 12 months prior to completing terminal degree requirements to 12 months after starting postdoctoral training), it is recognized that some applicants are unlikely to have had the opportunity to generate preliminary data for the proposed project. Accordingly, it is expected that there will be no preliminary data in the application, although the inclusion of preliminary data is permissible.

The proposed research and training plan should focus on a research area and/or skill set that clearly and strongly complements the applicant's existing research expertise and skills and that will markedly broaden the applicant's knowledge and skills. For example, an applicant with existing skills in molecular neuroscience might propose a research training plan that emphasizes circuit-level neuroscience approaches to brain function. An applicant with existing neuroscience training might propose a research training plan that emphasizes neuroethics. An applicant trained in physics or statistics might propose a research training plan that emphasizes data-intensive/computational approaches to neuroscience. An applicant with research experience using non-human vertebrate animals might propose a research training plan using human subjects.

The application should consist of a well-conceived scientific project, integrated with a comprehensive training plan, which is designed by a collaborative discussion between the applicant fellow and sponsor. In addition to preparing the candidate to be a subject matter expert in the proposed research area and to acquire new technical skills, the research and training plans are expected to provide the candidate with a strong understanding of the principles of experimental design and the tools for rigorous analytical approaches. Given that neuroethics research may involve the analysis of large qualitative data sets, applicants proposing research in this domain are expected to propose didactics and training that will develop state-of-the-art analytical skills appropriate for such data sets. In contrast, applicants proposing experimental neuroscience research and/or modeling are expected to propose didactics and training that will enable them to develop state-of-the-art quantitative skills, principles of quantitative analysis, and to incorporate quantitative approaches that are appropriate to answer the proposed research question. Applicants proposing a computational/modeling project are encouraged to gain exposure to the biological approaches from which the data sets they will model are derived. Further, the proposed research and training plan should enhance the individual's potential to develop into a productive, independent researcher by providing committed mentorship, appropriate training and career development opportunities, and strong institutional support. The training plan should document the need for, and the anticipated value of, the proposed mentored training in relation to the individual's research career goals and the individual's prior research training. The training plan should be explicitly designed to prepare the fellow to transition to the next stage of their research career.

It is expected that the mentored training experience will provide:

  • A strong foundation in quantitative reasoning, research design, methods, statistics, and analytic techniques appropriate to the proposed research and sufficient to ensure that the applicant has the knowledge and skills to generate robust and reproducible data;
  • Experience conducting research using appropriate, state-of-the-art tools and approaches relevant to the goals of the BRAIN Initiative and an expert understanding of the tools and methods used;
  • Opportunities to present research findings at national meetings as the work progresses;
  • Opportunities to publish the research findings as first author;
  • Opportunities to interact with members of the scientific community at appropriate scientific meetings and workshops, including annual BRAIN Initiative meetings; and
  • Professional skills needed to transition to the next stage of the applicant's research career.

To be considered responsive to this FOA, the proposed research training plan must be relevant to the scientific goals of the BRAIN 2025 Report, as described in the required Other Attachment for this application (see Section IV.2. SF424(R&R) Other Project Information below). Applications that are not relevant to one or more goals of the BRAIN 2025 report will not be reviewed.

Note: This FOA does not allow applicants to propose to lead an independent clinical trial but does allow applicants to propose research experience in a clinical trial led by a sponsor or co-sponsor.

Pre-Submission Consultation

Applicants are strongly encouraged to consult with NIH scientific/research staff when planning an application. Early contact provides an opportunity for NIH scientific/research staff to provide guidance on program scope and appropriateness of the proposed research and training for potential funding in response to this FOA. Applicants should contact NIH scientific/research staff as early as possible before the due date.

See Section VIII. Other Information for award authorities and regulations. new text

Section II. Award Information

Funding Instrument

Grant: A support mechanism providing money, property, or both to an eligible entity to carry out an approved project or activity.

Application Types Allowed
New
Resubmission

The OER Glossary and the SF424 (R&R) Application Guide provide details on these application types. Only those application types listed here are allowed for this FOA.

Clinical Trial?

Not Allowed: Only accepting applications that do not propose independent clinical trials.

Note: Applicants may propose to gain experience in a clinical trial led by a sponsor/co-sponsor as part of their research training.

Need help determining whether you are doing a clinical trial?

Funds Available and Anticipated Number of Awards

The BRAIN Initiative intends to commit $1.5M per year in FY 2024, FY 2025, and FY 2026 to fund an estimate of 20 awards per Fiscal Year.

Award Budget

Award budgets are composed of stipends, tuition and fees, and institutional allowance, as described below.

Award Project Period

Individuals may receive up to 3 years of aggregate Kirschstein-NRSA support at the postdoctoral level, including any combination of support from institutional training grants (e.g., T32) and an individual fellowship award.

Other Award Budget Information

Stipends

Kirschstein-NRSA awards provide stipends as a subsistence allowance to help defray living expenses during the research and clinical training experiences. See https://researchtraining.nih.gov/resources/policy-notices

Tuition and Fees

Fellowship awards will contribute to the combined cost of tuition and fees at the rate in place at the time of award. See https://researchtraining.nih.gov/resources/policy-notices

Institutional Allowance

The application should request a Kirschstein-NRSA institutional allowance to help defray the cost of fellowship expenses such as health insurance, research supplies, equipment, books, and travel to scientific meetings. In addition to the standard institutional allowance, the application may request up to $5,000 annually to defray the cost of participation in meetings including annual BRAIN Initiative meetings. See https://researchtraining.nih.gov/resources/policy-notices

Indirect Costs

Fellowship awards do not include a separate reimbursement for indirect costs (also known as Facilities & Administrative [F&A] Costs). Instead of costs for administering fellowships are covered by the Institutional Allowance. See https://researchtraining.nih.gov/resources/policy-notices

Stipend levels, as well as funding amounts for tuition and fees and the institutional allowance are announced annually in the NIH Guide for Grants and Contracts, and are also posted on the Ruth L. Kirschstein National Research Service Award (NRSA) webpage.

NIH grants policies as described in the NIH Grants Policy Statement will apply to the applications submitted and awards made from this FOA.

Section III. Eligibility Information

1. Eligible Applicants

Eligible Organizations

Higher Education Institutions

  • Public/State Controlled Institutions of Higher Education
  • Private Institutions of Higher Education

The following types of Higher Education Institutions are always encouraged to apply for NIH support as Public or Private Institutions of Higher Education:

  • Hispanic-serving Institutions
  • Historically Black Colleges and Universities (HBCUs)
  • Tribally Controlled Colleges and Universities (TCCUs)
  • Alaska Native and Native Hawaiian Serving Institutions
  • Asian American Native American Pacific Islander Serving Institutions (AANAPISIs)

Nonprofits Other Than Institutions of Higher Education

  • Nonprofits with 501(c)(3) IRS Status (Other than Institutions of Higher Education)
  • Nonprofits without 501(c)(3) IRS Status (Other than Institutions of Higher Education)

For-Profit Organizations

  • Small Businesses
  • For-Profit Organizations (Other than Small Businesses)

Governments

  • Eligible Agencies of the Federal Government
Other
  • Non-domestic (non-U.S.) Entities (Foreign Institutions)

The Kirschstein-NRSA F32 fellowship is designed to support research training experiences in new settings in order to maximize the acquisition of new skills and knowledge. In most cases, therefore, the sponsoring institution should be a site other than where the candidate trained as a graduate student. However, if the candidate is proposing postdoctoral training at their doctoral institution, the application must carefully document the opportunities for new research training experiences specifically designed to broaden their scientific background and to acquire new knowledge and/or technical skills that will enhance their potential to become a productive, independent investigator. Applications that propose postdoctoral experiences in the same lab, in fundamentally the same research environment or with the same primary mentor who supported the candidate's predoctoral experience, are inconsistent with the intent of this F32 program.

Before submitting a fellowship application, the candidate must identify a sponsoring institution. The sponsoring institution must have staff and facilities available on site to provide a suitable environment for performing high-quality research training. The training should occur in an environment that has appropriate human and technical resources and is demonstrably committed to training in the field(s) proposed by the candidate. The sponsoring institution may be private (profit or nonprofit) or public, including the NIH Intramural Programs and other Federal laboratories. All institutions with the appropriate resources and commitment are encouraged to apply.

An individual may request support for training abroad. In such cases, the applicant is required to provide detailed justification for the foreign training, including the reasons why the facilities, the sponsor, or other aspects of the proposed experience are more appropriate than training in a domestic setting. The justification is evaluated in terms of the scientific advantages of the foreign training as compared to the training available domestically. Foreign training will be considered for funding only when the scientific advantages are clear.

Foreign Institutions

Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply.

Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.

Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

Required Registrations

Applicant Organizations

Applicant organizations must complete and maintain the following registrations as described in the SF 424 (R&R) Application Guide to be eligible to apply for or receive an award. All registrations must be completed prior to the application being submitted. Registration can take 6 weeks or more, so applicants should begin the registration process as soon as possible. The NIH Policy on Late Submission of Grant Applications states that failure to complete registrations in advance of a due date is not a valid reason for a late submission.

  • System for Award Management (SAM) Applicants must complete and maintain an active registration, which requires renewal at least annually. The renewal process may require as much time as the initial registration. SAM registration includes the assignment of a Commercial and Government Entity (CAGE) Code for domestic organizations which have not already been assigned a CAGE Code.
  • NATO Commercial and Government Entity (NCAGE) Code Foreign organizations must obtain an NCAGE code (in lieu of a CAGE code) in order to register in SAM.
  • Unique Entity Identifier (UEI) A UEI is issued as part of the SAM.gov registration process. The same UEI must be used for all registrations, as well as on the grant application.
  • eRA Commons - Once the unique organization identifier is established, organizations can register with eRA Commons in tandem with completing their Grants.gov registration; all registrations must be in place by time of submission. eRA Commons requires organizations to identify at least one Signing Official (SO) and at least one Program Director/Principal Investigator (PD/PI) account in order to submit an application.
  • Grants.gov Applicants must have an active SAM registration in order to complete the Grants.gov registration.

Program Directors/Principal Investigators (PD(s)/PI(s))

All PD(s)/PI(s) must have an eRA Commons account. PD(s)/PI(s) should work with their organizational officials to either create a new account or to affiliate their existing account with the applicant organization in eRA Commons. If the PD/PI is also the organizational Signing Official, they must have two distinct eRA Commons accounts, one for each role. Obtaining an eRA Commons account can take up to 2 weeks.

All PD(s)/PI(s) must be registered with ORCiD. The personal profile associated with the PD(s)/PI(s) eRA Commons account must be linked to a valid ORCID ID. For more information on linking an ORCID ID to an eRA Commons personal profile see the ORCID topic in our eRA Commons online help.

Eligible Individuals (Program Director/Principal Investigator)

Any individual(s) with the skills, knowledge, and resources necessary to carry out the proposed research as the Program Director(s)/Principal Investigator(s) (PD(s)/PI(s)) is invited to work with their organization to develop an application for support. Individuals from diverse backgrounds, including underrepresented racial and ethnic groups, individuals with disabilities, and women are always encouraged to apply for NIH support. See, Reminder: Notice of NIH's Encouragement of Applications Supporting Individuals from Underrepresented Ethnic and Racial Groups as well as Individuals with Disabilities, NOT-OD-22-019.

By the time of award, the individual must be a citizen or a non-citizen national of the United States or have been lawfully admitted for permanent residence (i.e., possess a currently valid Permanent Resident Card USCIS Form I-551, or other legal verification of such status).

Applicants are strongly encouraged to apply for this funding opportunity before they have completed their terminal doctoral degree requirements, so that this fellowship award may begin early in their postdoctoral training period and maximize this award's training potential. Applications are encouraged from individuals who expect to complete their terminal doctoral degree requirements within 12 months of the application due date. On the application due date, candidates may not have completed more than 12 months of postdoctoral training, as measured from the completion of all doctoral degree requirements. If requested, applicants should be prepared to provide a letter signed by the director of their degree program and countersigned by an authorized institutional representative.

Parental leave or other well-justified leave for personal or family situations of generally less than 12 months duration (e.g., family care responsibilities, disability or illness, active military duty) is not included in the 12-month postdoctoral eligibility limit. Part-time postdoctoral research, related to personal or family situations, will be pro-rated accordingly. In addition, time spent conducting postgraduate clinical training that does not involve research is not considered as part of the 12 month postdoctoral training eligibility limit. Only time dedicated to research activities would count toward the limit. Potential applicants are encouraged to consult NIH scientific/research staff if they have any questions regarding their eligibility.

Applicants completing terminal doctoral degrees in quantitative disciplines, e.g., statistics, computer science, physics, mathematics, and engineering, are eligible and encouraged to apply for this FOA.

Before a Kirschstein-NRSA postdoctoral fellowship award can be activated, the individual must have received a PhD, MD, DO, DC, DDS, DVM, OD, DPM, ScD, EngD, DrPH, DNSc, ND (Doctor of Naturopathy), PharmD, DSW, PsyD, or equivalent doctoral degree from an accredited domestic or foreign institution. Certification by an authorized official of the degree-granting institution that all degree requirements have been met is also acceptable. A Kirschstein-NRSA fellowship may not be used to support the clinical years of residency training. However, these awards are appropriate for the research fellowship years of a residency program. Research clinicians must devote full-time to their proposed research training and confine clinical duties to those activities that are part of the research training program.

2. Cost Sharing

This FOA does not require cost sharing as defined in the NIH Grants Policy Statement.

3. Additional Information on Eligibility

Number of Applications

The NIH will not accept duplicate or highly overlapping applications under review at the same time, per 2.3.7.4 Submission of Resubmission Application. This means that the NIH will not accept:

  • A new (A0) application that is submitted before issuance of the summary statement from the review of an overlapping new (A0) or resubmission (A1) application.
  • A resubmission (A1) application that is submitted before issuance of the summary statement from the review of the previous new (A0) application.
  • An application that has substantial overlap with another application pending appeal of initial peer review.
Duration of Support

Individuals may not exceed the aggregate limit of NRSA support shown above in the Award Project Period (see Section II. Award Information). Candidates must consider any prior NRSA research training in determining the duration of support requested. Information regarding previous Kirschstein-NRSA support must be included in the application and will be considered at the time of award.

Level of Effort

At the time of award, individuals are required to pursue their research training on a full-time basis, normally defined as 40 hours per week or as specified by the sponsoring institution in accordance with its own policies.

Sponsor

Before submitting the application, the candidate must identify a sponsor(s) who will supervise the proposed mentored training experience. Candidates are encouraged to identify more than one sponsor, i.e., a sponsor team, if this is deemed advantageous for their training program. When there is a sponsor team, one individual must be identified as the primary sponsor, and will be expected to coordinate the candidate's overall training.

The primary sponsor should be an active investigator in the area of the proposed research training and be committed both to the candidate’s research training and to direct supervision of his/her research. The primary sponsor must document the availability of sufficient research funds and facilities for high-quality research training. The primary sponsor, or a member of the sponsor team, should have a successful track record of mentorship. The candidate must work with the primary sponsor(s) in preparing the application.

Importantly, however, the proposed research project should derive from the collaborative intellectual input of the applicant fellow and sponsor(s).

For this FOA, applicants are strongly encouraged to select a primary sponsor with whom they have not collaborated during their predoctoral training period so as to maximize training potential of the award (see also Section III.1. Eligible Organizations above).

For this FOA, at least the primary sponsor should have research expertise relevant to one or more of the goals described in the BRAIN 2025 Report; however, the sponsor is not required to have direct funding from the BRAIN Initiative.

Section IV. Application and Submission Information

1. Requesting an Application Package

The application forms package specific to this opportunity must be accessed through ASSIST, Grants.gov Workspace or an institutional system-to-system solution. Links to apply using ASSIST or Grants.gov Workspace are available in Part 1 of this FOA. See your administrative office for instructions if you plan to use an institutional system-to-system solution.

2. Content and Form of Application Submission

It is critical that applicants follow the Fellowship (F) instructions in the SF424 (R&R) Application Guide, except where instructed in this funding opportunity announcement to do otherwise. Conformance to the requirements in the Application Guide is required and strictly enforced. Applications that are out of compliance with these instructions may be delayed or not accepted for review.

Page Limitations

All page limitations described in the SF424 Application Guide and the Table of Page Limits must be followed.

Letter of Intent

Although a letter of intent is not required, is not binding, and does not enter into the review of a subsequent application, the information that it contains allows IC staff to estimate the potential review workload and plan the review.
By the date listed in Part 1. Overview Information, prospective applicants are asked to submit a letter of intent that includes the following information:

Descriptive title of proposed activity
Name(s), address(es), and telephone number(s) of the PD(s)/PI(s)
Names of other key personnel
Participating institution(s)
Number and title of this funding opportunity

The letter of intent should be sent to:
Ashlee Van't Veer, PhD
Email: Brain.Initiative.Training@nih.gov

Instructions for Application Submission

The following section supplements the instructions found in the SF424 (R&R) Application Guide and should be used for preparing an application to this FOA.

Instructions for Application Submission
SF424(R&R) Cover

All instructions in the SF424 (R&R) Application Guide must be followed.

SF424(R&R) Project/Performance Site Locations

All instructions in the SF424 (R&R) Application Guide must be followed.

Other Project Information

All instructions in the SF424 (R&R) Application Guide must be followed, with the following additional instructions:.

Facilities & Other Resources: Include a description of how the scientific environment is specifically conducive to the proposed research training in one or more of the high-priority areas described in the BRAIN 2025 Report.

Other Attachments: Attach a one-page description of the relationship of the proposed Research Training Plan to one or more of the specific goals stated in the BRAIN 2025 Report. The first sentence of this description should state which of the seven, high-priority goals enumerated in this Report is addressed by your Research Training Plan. Name this file: BRAIN Relationship.

The filename provided for each Other Attachment will be the name used for the bookmark in the electronic application in eRA Commons.

SF424(R&R) Senior/Key Person Profile Expanded

All instructions in the SF424 (R&R) Application Guide must be followed.

IMPORTANT REMINDER: The personal profile associated with the eRA Commons username entered in the Credential field for the PD/PI (fellowship applicant) must include an ORCID ID. For more information on linking an ORCID ID to an eRA Commons personal profile see the ORCID topic in our eRA Commons online help

Candidate Biographical Sketch: Clearly indicate the anticipated or actual date (month and year) doctoral degree requirements will be/were completed.

Sponsor(s) Biographical Sketch: As part of the Personal Statement, describe research expertise relevant to the goals of the BRAIN Initiative and the candidate's proposed research training plan.

PHS Fellowship Supplemental Form

The PHS Fellowship Supplemental Form is comprised of the following sections:

  • Fellowship Applicant
  • Research Training Plan
  • Sponsor(s), Collaborator(s), and Consultant(s);
  • Institutional Environment & Commitment to Training
  • Other Research Training Plan Sections
  • Additional Information
  • Budget
  • Appendix

All instructions in the SF424 (R&R) Application Guide must be followed.

Fellowship Applicant Section

Applicant’s Background and Goals for Fellowship Training

Describe your current and prior research experience, making clear how it is distinguished from the proposed research training and how it has prepared you for the proposed project. Describe the planned activities that will provide you with a strong foundation in quantitative reasoning, rigorous research design, and experimental methods, statistics and analytic techniques appropriate to the proposed research. Make clear how the training goals and planned activities will contribute to development of the technical skills, conceptual approaches, scientific knowledge, and professional skills needed for you to contribute to advancing the goals of the BRAIN 2025 Report, and to transition to the next stage of your research career.

Describe the planned opportunities to present research findings at national meetings, publish the research findings as first author, and interact with members of the scientific community at appropriate scientific meetings and workshops including BRAIN Initiative investigator meetings.

Research Training Plan

All instructions in the SF424 (R&R) Application Guide must be followed, with the following additional instructions:

Research Strategy

Relate the proposed project to the BRAIN Initiative. Given that this FOA is intended for early postdoctoral research training, it is not expected that applicants will include their own preliminary results. However, applicants are encouraged to address technical feasibility; document previously published work that supports the proposed project and technical approaches; describe potential pitfalls; and describe alternative approaches should the proposed approach not prove viable.

Sponsor(s), Collaborator(s), and Consultant(s)

All instructions in the SF424 (R&R) Application Guide must be followed, with the following additional instructions:

Sponsor and Co-Sponsor Statements

  • The Sponsor and any Co-Sponsors should describe their qualifications to train a postdoctorate who seeks mentored training in a research area relevant to the goals of the BRAIN Initiative.
  • State how the proposed mentored training provides a new research direction for the candidate and how it provides a foundation for a research career relevant to the goals of the BRAIN Initiative.
  • Document a detailed plan of mentored research training, including any necessary didactics to ensure that the applicant acquires robust grounding in experimental design, statistics, and other analytical tools appropriate for the proposed research area; and mentored professional development.
  • Provide a milestone-driven timeline to assess the applicant's progress during the award period, and describe how any necessary guided course-correction will be achieved to ensure that the applicant makes strong progress toward the proposed research and career development goals.
  • Describe a specific plan by which the applicant's transition to the next step of their research career will be facilitated during this fellowship award. Describe a plan for clear separation of the candidate's research and research career from the sponsor's research, including identifying the components of the research plan that the candidate may take.
  • The Sponsor should also describe the roles and responsibilities that both theyhe/she and the fellow are undertaking, including contributions to the research plan, the portion of the research ideas and plan that originated with the candidate, and the relationship between the proposed research plan and funded or unfunded research projects previously devised by the sponsor.
  • If the applicant is proposing to gain experience in a clinical trial as part of theirhis or he research training, the sponsor or co-sponsor must include a statement to document leadership of the clinical trial including source of funding, National Clinical Trial number (NCT#) and appropriate expertise to guide the applicant in any proposed clinical trials research experience. The individual receiving support for the clinical trial (i.e., the sponsor/primary mentor or a co-sponsor) is the responsible individual of record for oversight of the trial though fellows can take part in all components of a clinical trial. Oversight includes (but is not limited to): interacting with relevant Institutional Review Board (IRB) staff; reviewing all informed consent documents; reporting potential serious adverse events; and maintaining responsibility for patient safety. However, the fellow can gain experience in all these components in conjunction with the mentor or individual leading the trial.

Institutional Environment and Commitment to Training Section

Description of Institutional Environment and Commitment to Training

Describe the institutional opportunities available to the applicant to develop professional skills, e.g., communication skills, grant-writing skills, laboratory management, leadership, and preparing future faculty. Describe the contribution of the sponsor and sponsor's research environment to development of these skills, and describe the opportunities available to the applicant that are independent of the sponsor.

Appendix

Limited items are allowed in the Appendix. Follow all instructions for the Appendix as described in the SF424 (R&R) Application Guide; any instructions provided here are in addition to the SF424 (R&R) Application Guide instructions.

PHS Human Subjects and Clinical Trials Information

When involving human subjects research, clinical research, and/or NIH-defined clinical trials (and when applicable, clinical trials research experience) follow all instructions for the PHS Human Subjects and Clinical Trials Information form in the SF424 (R&R) Application Guide, with the following additional instructions:

If you answered Yes to the question Are Human Subjects Involved? on the R&R Other Project Information form, you must include at least one human subjects study record using the Study Record: PHS Human Subjects and Clinical Trials Information form or Delayed Onset Study record.

Study Record: PHS Human Subjects and Clinical Trials Information

All instructions in the SF424 (R&R) Application Guide must be followed.

  • Do not provide an NCT# in Section 1, item 1.5. See instruction for Sponsor(s), Collaborator(s), and Consultant(s) above.
  • Do not complete Section 4 - Protocol Synopsis information or Section 5 - Other Clinical Trial-related Attachments.

Delayed Onset Study

Note: Delayed onset does NOT apply to a study that can be described, but will not start immediately (i.e., delayed start).

All instructions in the SF424 (R&R) Application Guide must be followed.

PHS Assignment Request Form
All instructions in the SF424 (R&R) Application Guide must be followed.
Reference Letters

Applicants must carefully follow the SF424 (R&R) Application Guide, including the time period for when reference letters will be accepted. Applications lacking the appropriate required reference letters will not be reviewed. This is a separate process from submitting an application electronically. Reference letters are submitted directly through the eRA Commons Submit Reference Letter link and not through Grants.gov.

Foreign Institutions

Foreign (non-U.S.) institutions must follow policies described in the NIH Grants Policy Statement, and procedures for foreign institutions described throughout the SF424 (R&R) Application Guide.

3. Unique Entity Identifier and System for Award Management (SAM)

See Part 1. Section III.1 for information regarding the requirement for obtaining a unique entity identifier and for completing and maintaining active registrations in System for Award Management (SAM), NATO Commercial and Government Entity (NCAGE) Code (if applicable), eRA Commons, and Grants.gov

4. Submission Dates and Times

Part I. Overview Information contains information about Key Dates and times. Applicants are encouraged to submit applications before the due date to ensure they have time to make any application corrections that might be necessary for successful submission. When a submission date falls on a weekend or Federal holiday, the application deadline is automatically extended to the next business day.

Organizations must submit applications to Grants.gov (the online portal to find and apply for grants across all Federal agencies). Applicants must then complete the submission process by tracking the status of the application in the eRA Commons, NIH’s electronic system for grants administration. NIH and Grants.gov systems check the application against many of the application instructions upon submission. Errors must be corrected and a changed/corrected application must be submitted to Grants.gov on or before the application due date and time. If a Changed/Corrected application is submitted after the deadline, the application will be considered late. Applications that miss the due date and time are subjected to the NIH Policy on Late Application Submission.

Applicants are responsible for viewing their application before the due date in the eRA Commons to ensure accurate and successful submission.

Information on the submission process and a definition of on-time submission are provided in the SF424 (R&R) Application Guide.

5. Intergovernmental Review (E.O. 12372)

This initiative is not subject to intergovernmental review.

6. Funding Restrictions

All NIH awards are subject to the terms and conditions, cost principles, and other considerations described in the NIH Grants Policy Statement. The National Research Service Award (NRSA) policies apply to this program. A Kirschstein-NRSA fellowship may not be held concurrently with another federally sponsored fellowship or similar Federal award that provides a stipend or otherwise duplicates provisions of this award.

Pre-award costs are generally not allowable for Fellowships.

7. Other Submission Requirements and Information

Applications must be submitted electronically following the instructions described in the SF424 (R&R) Application Guide. Paper applications will not be accepted.

Applicants must complete all required registrations before the application due date. Section III. Eligibility Information contains information about registration.

For assistance with your electronic application or for more information on the electronic submission process, visit How to Apply Application Guide. If you encounter a system issue beyond your control that threatens your ability to complete the submission process on-time, you must follow the Dealing with System Issues guidance. For assistance with application submission, contact the Application Submission Contacts in Section VII.

Important reminders:

All PD(s)/PI(s) and sponsor(s) must include their eRA Commons ID in the Credential field of the Senior/Key Person Profile form. Failure to register in the Commons and to include a valid PD/PI Commons ID in the credential field will prevent the successful submission of an electronic application to NIH.

The applicant organization must ensure that the unique entity identifier provided on the application is the same identifier used in the organization’s profile in the eRA Commons and for the System for Award Management. Additional information may be found in the SF424 (R&R) Application Guide.

See more tips for avoiding common errors.

Upon receipt, applications will be evaluated for completeness and compliance with application instructions by the Center for Scientific Review and responsiveness by components of participating organizations, NIH. Applications that are incomplete, non-compliant and/or nonresponsive will not be reviewed.

Use of Common Data Elements in NIH-funded Research

Many NIH ICs encourage the use of common data elements (CDEs) in basic, clinical, and applied research, patient registries, and other human subject research to facilitate broader and more effective use of data and advance research across studies. CDEs are data elements that have been identified and defined for use in multiple data sets across different studies. Use of CDEs can facilitate data sharing and standardization to improve data quality and enable data integration from multiple studies and sources, including electronic health records. NIH ICs have identified CDEs for many clinical domains (e.g., neurological disease), types of studies (e.g. genome-wide association studies (GWAS)), types of outcomes (e.g., patient-reported outcomes), and patient registries (e.g., the Global Rare Diseases Patient Registry and Data Repository). NIH has established a Common Data Element (CDE) Resource Portal" (http://cde.nih.gov/) to assist investigators in identifying NIH-supported CDEs when developing protocols, case report forms, and other instruments for data collection. The Portal provides guidance about and access to NIH-supported CDE initiatives and other tools and resources for the appropriate use of CDEs and data standards in NIH-funded research. Investigators are encouraged to consult the Portal and describe in their applications any use they will make of NIH-supported CDEs in their projects.

Post Submission Materials

Applicants are required to follow the instructions for post-submission materials, as described in the policy.

Section V. Application Review Information

1. Criteria

Only the review criteria described below will be considered in the review process. Applications submitted to the NIH in support of the NIH mission are evaluated for scientific and technical merit through the NIH peer review system.

Note: Effective for due dates on or after January 25, 2023, the Data Sharing Plan and Genomic Data Sharing Plan (GDS) will not be evaluated at time of review.

For this particular announcement, note the following:

  • A fellowship application has a research project that is integrated with the training plan. The review will emphasize the candidate’s potential for a productive career, the candidate’s need for the proposed training, and the degree to which the research project and training plan, the sponsor(s), and the environment will satisfy those needs.
Overall Impact

Reviewers will provide an overall impact score to reflect their assessment of the likelihood that the fellowship will enhance the candidate’s potential for, and commitment to, a productive independent scientific research career in a health-related field, in consideration of the scored and additional review criteria.

Scored Review Criteria

Reviewers will consider each of the review criteria below in the determination of scientific merit, and give a separate score for each. An application does not need to be strong in all categories to be judged likely to have major scientific impact.

  • To what degree are the candidate’s academic record and research experience of high quality?
  • How strong is the candidate’s potential to develop into an independent and productive researcher?
  • To what extent does the research project reflect a significant contribution of the candidate to the originality of the project idea, approach and/or hypotheses?
  • To what degree has the applicant been appropriately productive during the predoctoral training period?
  • How appropriate are the sponsor(s ) research qualifications (including recent publications) and track record of mentoring individuals at a similar stage for the needs of the candidate?
  • How aligned are the research and clinical interests (if applicable) of the candidate and the sponsor(s)? How well do(es) the sponsor(s) demonstrate an understanding of the candidate’s training needs as well as the ability and commitment to assist in meeting these needs?
  • How adequate are the research funds to support the candidate’s proposed research project and training for the duration of the research component of the fellowship?
  • If a team of sponsors is proposed, how strong is the justification for team structure for the mentored training plan, and how well are the roles of the individual members defined?
  • To what extent are the qualifications of any collaborator(s) and/or consultant(s), including their complementary expertise and previous experience in fostering the training of fellows, appropriate for the proposed project? Were letters provided by collaborators and consultants that describe and confirm their commitment to the project?
  • If the applicant is proposing to gain experience in a clinical trial as part of his or her research training, to what degree is there evidence of the appropriate expertise, experience, resources, and ability on the part of the sponsor(s) to guide the applicant during the clinical trial research experience?
  • How well does the sponsor's mentoring statement, as well as their training record, indicate that the candidate will receive rigorous mentored training in the proposed research area, in methodology relevant to the project, experimental design, and analytical skills, including quantitative skills as appropriate for the proposed project?
  • To what extent does the sponsor(s) have appropriate expertise to guide the candidate in high-quality research training that is relevant to the goals of the BRAIN Initiative?
  • To what extent does the primary sponsor provide a new direction for the candidate's research training, with no history of prior collaboration with the applicant?
  • How well does the sponsor provide a milestone-driven timeline to assess the candidate's progress during the award period, and a plan to facilitate the applicant's transition to the next step in their research career?
  • How acceptable is the sponsor(s') plan for clear separation of the candidate's research and research career from the sponsor's research, including identifying the components of the research plan that the candidate may take to an extramural research position?
  • To what extent is the proposed research project of high scientific quality and well integrated with the proposed research training plan?
  • Based on the sponsor’s description of their active research program, how distinct is the candidate’s proposed research project from the sponsor’s funded research for the candidate’s career stage?
  • How consistent is the research project with the candidate’s stage of research development?
  • How feasible is the proposed time frame to accomplish the proposed training?
  • To what extent does the training plan provide opportunities to present and publish research findings and meet with scientists in the community at national meetings as the work progresses?
  • To what degree will the training plan provide the professional skills needed for the candidate to transition to the next stage of their research career?
  • To what extent do the discussion of expected results, and potential pitfalls and alternative outcomes provide confidence that, if an important component of the research is unsuccessful, the applicant is likely to have a viable direction for continuing the project?
  • If proposed, will the clinical trial experience contribute to the proposed project and/or the applicant’s research training?
  • How rigorous is the prior research that serves as the key support for the proposed project?
  • How developed are the plans to address weaknesses in the rigor of prior research that serves as the key support for the proposed project?
  • How robust and unbiased are the approach strategies for the proposed work?
  • How adequate are the plans to address relevant biological variables, such as sex, for studies in vertebrate animals or human subjects?

  • To what extent will the proposed research project and training plan provide the candidate with the requisite individualized and mentored experiences to obtain appropriate skills for a research career?
  • To what extent does the training plan provide needed skills and address gaps in the candidate's training?
  • To what extent does the training plan document a clear need for, and value of, the proposed training?
  • To what extent does the proposed training have the potential to serve as a sound foundation that will clearly enhance the candidate’s ability to develop into a productive researcher?
  • To what degree does the proposed research training occur in an area that clearly complements the applicant's doctoral research training?
  • How well does the proposed training ensure the applicant gains robust analytical skills, including quantitative reasoning, experimental design, statistics, and other analytical tools appropriate for the research area?
  • How prepared will the applicant be to launch an independent research career from the proposed plan, including gaining rigorous research training and related professional skills?
  • To what degree are the research facilities, resources (e.g., equipment, laboratory space, computer time, subject populations), and training opportunities (e.g., seminars, workshops, professional development opportunities) adequate and appropriate?
  • To what extent is the institutional environment for the candidate’s scientific development of high quality?
  • How strong is the institutional commitment to fostering the candidate’s mentored training?
  • To what extent is the institutional environment appropriate for postdoctoral training using cutting-edge neuroscience tools and technologies?
  • How well does the institutional and/or laboratory environment provide appropriate and sufficient opportunities for the applicant to gain the professional skills needed for a successful research career?
Additional Review Criteria

As applicable for the project proposed, reviewers will evaluate the following additional items while determining scientific and technical merit, and in providing an overall impact score, but will not give separate scores for these items.

When the proposed project involves human subjects and/or NIH-defined clinical research, the committee will evaluate the proposed plans for the inclusion (or exclusion) of individuals on the basis of sex/gender, race, and ethnicity, as well as the inclusion (or exclusion) of individuals of all ages (including children and older adults) to determine if it is justified in terms of the scientific goals and research strategy proposed. For additional information on review of the Inclusion section, please refer to the Guidelines for the Review of Inclusion in Clinical Research.

For research that involves human subjects but does not involve one of the categories of research that are exempt under 45 CFR Part 46, the committee will evaluate the justification for involvement of human subjects and the proposed protections from research risk relating to their participation according to the following five review criteria: 1) risk to subjects, 2) adequacy of protection against risks, 3) potential benefits to the subjects and others, 4) importance of the knowledge to be gained, and 5) data and safety monitoring for clinical trials.

For research that involves human subjects and meets the criteria for one or more of the categories of research that are exempt under 45 CFR Part 46, the committee will evaluate: 1) the justification for the exemption, 2) human subjects involvement and characteristics, and 3) sources of materials. For additional information on review of the Human Subjects section, please refer to the Guidelines for the Review of Human Subjects.

The committee will evaluate the involvement of live vertebrate animals as part of the scientific assessment according to the following criteria: (1) description of proposed procedures involving animals, including species, strains, ages, sex, and total number to be used; (2) justifications for the use of animals versus alternative models and for the appropriateness of the species proposed; (3) interventions to minimize discomfort, distress, pain and injury; and (4) justification for euthanasia method if NOT consistent with the AVMA Guidelines for the Euthanasia of Animals. Reviewers will assess the use of chimpanzees as they would any other application proposing the use of vertebrate animals. For additional information on review of the Vertebrate Animals section, please refer to the Worksheet for Review of the Vertebrate Animals Section.

For Resubmissions, the committee will evaluate the application as now presented, taking into consideration the responses to comments from the previous scientific review group and changes made to the project.

Not Allowed

Not Applicable.

Additional Review Considerations

As applicable for the project proposed, reviewers will consider each of the following items, but will not give scores for these items, and should not consider them in providing an overall impact score.

All applications for support under this FOA must include a plan to fulfill NIH requirements for Instruction in the Responsible Conduct of Research (RCR). Taking into account the level of experience of the candidate, including any prior instruction or participation in RCR as appropriate for the candidate’s career stage, the reviewers will evaluate the adequacy of the proposed RCR training in relation to the following five required components: 1) Format - the required format of instruction, i.e., face-to-face lectures, coursework, and/or real-time discussion groups (a plan with only on-line instruction is not acceptable); 2) Subject Matter - the breadth of subject matter, e.g., conflict of interest, authorship, data management, human subjects and animal use, laboratory safety, research misconduct, research ethics; 3) Faculty Participation - the role of the sponsor(s) and other faculty involvement in the fellow’s instruction; 4) Duration of Instruction - the number of contact hours of instruction (at least eight contact hours are required); and 5) Frequency of Instruction instruction must occur during each career stage and at least once every four years. Plans and past record will be rated as ACCEPTABLE or UNACCEPTABLE, and the summary statement will provide the consensus of the review committee. See also: NOT-OD-10-019 and NOT-OD-22-055.

Reviewers will assess whether the project presents special opportunities for furthering research programs through the use of unusual talent, resources, populations, or environmental conditions that exist in other countries and either are not readily available in the United States or augment existing U.S. resources.

Reviewers will assess the information provided in this section of the application, including 1) the Select Agent(s) to be used in the proposed research, 2) the registration status of all entities where Select Agent(s) will be used, 3) the procedures that will be used to monitor possession use and transfer of Select Agent(s), and 4) plans for appropriate biosafety, biocontainment, and security of the Select Agent(s).

Note: Effective for due dates on or after January 25, 2023, the Data Sharing Plan and Genomic Data Sharing Plan (GDS) will not be evaluated at time of review.

Reviewers will comment on whether the Resource Sharing Plan(s) (i.e., Sharing Model Organisms) or the rationale for not sharing the resources, is reasonable.

For projects involving key biological and/or chemical resources, reviewers will comment on the brief plans proposed for identifying and ensuring the validity of those resources.

Reviewers will consider whether the budget and the requested period of support are fully justified and reasonable in relation to the proposed research.

2. Review and Selection Process

Applications will be evaluated for scientific and technical merit by (an) appropriate Scientific Review Group(s) convened by NIMH, in accordance with NIH peer review policy and procedures, using the stated review criteria. Assignment to a Scientific Review Group will be shown in the eRA Commons.

As part of the scientific peer review, all applications will receive a written critique.

Applications may undergo a selection process in which only those applications deemed to have the highest scientific and technical merit (generally the top half of applications under review) will be discussed and assigned an overall impact score.

Appeals of initial peer review will not be accepted for applications submitted in response to this FOA.

Applications will be assigned to the appropriate NIH Institute or Center. Applications will compete for available funds with all other recommended applications submitted in response to this FOA. Following initial peer review, recommended applications will receive a second level of review by the National Advisory Mental Health Council.The following will be considered in making funding decisions:

  • Scientific and technical merit of the proposed project as determined by scientific peer review.
  • Availability of funds.
  • Relevance of the proposed project to program priorities

3. Anticipated Announcement and Award Dates

After the peer review of the application is completed, the PD/PI will be able to access his or her Summary Statement (written critique) via the eRA Commons. Refer to Part 1 for dates for peer review, advisory council review, and earliest start date.

Information regarding the disposition of applications is available in the NIH Grants Policy Statement.

Section VI. Award Administration Information

1. Award Notices

If the application is under consideration for funding, NIH will request "just-in-time" information from the applicant as described in the NIH Grants Policy Statement.

A formal notification in the form of a Notice of Award (NoA) will be provided to the applicant organization for successful applications. The NoA signed by the grants management officer is the authorizing document and will be sent via email to the recipient's business official.

Recipients must comply with any funding restrictions described in Section IV.6. Funding Restrictions. Selection of an application for award is not an authorization to begin performance. Any costs incurred before receipt of the NoA are at the recipient's risk. These costs may be reimbursed only to the extent considered allowable pre-award costs.

Any application awarded in response to this FOA will be subject to terms and conditions found on the Award Conditions and Information for NIH Grants website. This includes any recent legislation and policy applicable to awards that is highlighted on this website.

Institutional Review Board or Independent Ethics Committee Approval: Recipient institutions must ensure that protocols are reviewed by their IRB or IEC. To help ensure the safety of participants enrolled in NIH-funded studies, the recipient must provide NIH copies of documents related to all major changes in the status of ongoing protocols.

2. Administrative and National Policy Requirements

All NIH grant and cooperative agreement awards include the NIH Grants Policy Statement as part of the NoA. For these terms of award, see the NIH Grants Policy Statement Part II: Terms and Conditions of NIH Grant Awards, Subpart A: General and Part II: Terms and Conditions of NIH Grant Awards, Subpart B: Terms and Conditions for Specific Types of Grants, Recipients, and Activities, including of note, but not limited to:

If a recipient is successful and receives a Notice of Award, in accepting the award, the recipient agrees that any activities under the award are subject to all provisions currently in effect or implemented during the period of the award, other Department regulations and policies in effect at the time of the award, and applicable statutory provisions.

Should the applicant organization successfully compete for an award, recipients of federal financial assistance (FFA) from HHS will be required to complete an HHS Assurance of Compliance form (HHS 690) in which the recipient agrees, as a term and condition of receiving the grant, to administer their programs in compliance with federal civil rights laws that prohibit discrimination on the basis of race, color, national origin, age, sex and disability, and agreeing to comply with federal conscience laws, where applicable. This includes ensuring that entities take meaningful steps to provide meaningful access to persons with limited English proficiency; and ensuring effective communication with persons with disabilities. Where applicable, Title XI and Section 1557 prohibit discrimination on the basis of sexual orientation, and gender identity. The HHS Office for Civil Rights provides guidance on complying with civil rights laws enforced by HHS. Please see https://www.hhs.gov/civil-rights/for-providers/provider-obligations/index.html and https://www.hhs.gov/civil-rights/for-individuals/nondiscrimination/index.html

HHS recognizes that research projects are often limited in scope for many reasons that are nondiscriminatory, such as the principal investigator’s scientific interest, funding limitations, recruitment requirements, and other considerations. Thus, criteria in research protocols that target or exclude certain populations are warranted where nondiscriminatory justifications establish that such criteria are appropriate with respect to the health or safety of the subjects, the scientific study design, or the purpose of the research. For additional guidance regarding how the provisions apply to NIH grant programs, please contact the Scientific/Research Contact that is identified in Section VII under Agency Contacts of this FOA.

Please contact the HHS Office for Civil Rights for more information about obligations and prohibitions under federal civil rights laws at https://www.hhs.gov/ocr/about-us/contact-us/index.html or call 1-800-368-1019 or TDD 1-800-537-7697.

Cooperative Agreement Terms and Conditions of Award

As specified in the NIH Revitalization Act of 1993, Kirschstein-NRSA recipients incur a service payback obligation for the first 12 months of postdoctoral support. Policies regarding the Kirschstein-NRSA payback obligation are explained in the NIH Grants Policy Statement; applicants may also wish to review Frequently Asked Questions for more details. The taxability of stipends is described in the NIH Grants Policy Statement.

Inventions and Copyrights

Fellowships funded primarily for educational purposes are exempted from the PHS invention requirements and thus invention reporting is not required. More details, including exceptions for fellows training at NIH are provided in the NIH Grants Policy Statement.

3. Data Management and Sharing

Note: The NIH Policy for Data Management and Sharing is effective for due dates on or after January 25, 2023.

Consistent with the NIH Policy for Data Management and Sharing, when data management and sharing is applicable to the award, recipients will be required to adhere to the Data Management and Sharing requirements as outlined in the NIH Grants Policy Statement. Upon the approval of a Data Management and Sharing Plan, it is required for recipients to implement the plan as described.

4. Reporting

When multiple years are involved, recipients will be required to submit the Research Performance Progress Report (RPPR) annually. The report is due two months before the beginning date of the next budget period and must include information describing the current year's progress as well as the research and training plans for the coming year.

NIH FOAs outline intended research goals and objectives. Post award, NIH will review and measure performance based on the details and outcomes that are shared within the RPPR, as described at 45 CFR Part 75.301 and 2 CFR 200.301.

The Federal Funding Accountability and Transparency Act of 2006 (Transparency Act), includes a requirement for recipients of Federal grants to report information about first-tier subawards and executive compensation under Federal assistance awards issued in FY2011 or later. All recipients of applicable NIH grants and cooperative agreements are required to report to the Federal Subaward Reporting System (FSRS) available at www.fsrs.gov on all subawards over the threshold. See the NIH Grants Policy Statement for additional information on this reporting requirement.

Other Fellowship Reporting Requirements:

  • Individuals admitted to the United States as Permanent Residents must submit notarized evidence of legal admission prior to the award.
  • The fellowship award recipient has up to six months from the issue date on the Notice of Award to activate the award using the Kirschstein-NRSA Individual Fellowship Activation Notice (PHS 416-5). Under unusual circumstances, the activation period may be extended at the request of the fellow. Such a request must be countersigned by the sponsor and an authorized institutional official.
  • For the individual's initial 12 months of Kirschstein-NRSA postdoctoral support, a signed, original Payback Agreement Form (PHS 6031) must accompany the Activation Notice.
  • At the conclusion of a fellowship, the fellow must submit a Termination Notice (PHS 416-7) via xTrain to the NIH within 30 days of termination. Fellows with service payback requirements must notify the NIH of any change in address and submit Annual Payback Activities Certification Forms (PHS 6031-1) until the payback service obligation is satisfied

5. Evaluation

In carrying out its stewardship of human resource-related programs, the NIH may request information essential to an assessment of the effectiveness of this program from databases and from participants themselves. Participants may be contacted after the completion of this award for periodic updates on various aspects of their employment history, publications, support from research grants or contracts, honors and awards, professional activities, and other information helpful in evaluating the impact of the program.

Section VII. Agency Contacts

We encourage inquiries concerning this funding opportunity and welcome the opportunity to answer questions from potential candidates.

Application Submission Contacts

eRA Service Desk (Questions regarding ASSIST, eRA Commons, application errors and warnings, documenting system problems that threaten submission by the due date, and post-submission issues)

Finding Help Online: https://www.era.nih.gov/need-help (preferred method of contact)
Telephone: 301-402-7469 or 866-504-9552 (Toll Free)

General Grants Information (Questions regarding application instructions, application processes, and NIH grant resources)
Email: GrantsInfo@nih.gov (preferred method of contact)
Telephone: 301-480-7075

Grants.gov Customer Support (Questions regarding Grants.gov registration and Workspace)
Contact Center Telephone: 800-518-4726
Email: support@grants.gov

Scientific/Research Contact(s)

Ashlee Van't Veer, PhD
National Institute of Mental Health (NIMH)
Telephone: 301-443-3107
Email: Brain.Initiative.Training@nih.gov

Peer Review Contact(s)

Nick Gaiano, PhD
National Institute of Mental Health (NIMH)
Telephone: 301-827-3420
Email: nick.gaiano@nih.gov

Financial/Grants Management Contact(s)

Craig Winters
National Institute of Mental Health (NIMH)
Telephone: 301-451-9948
Email: craig.winters@nih.gov

Section VIII. Other Information

Recently issued trans-NIH policy notices may affect your application submission. A full list of policy notices published by NIH is provided in the NIH Guide for Grants and Contracts. All awards are subject to the terms and conditions, cost principles, and other considerations described in the NIH Grants Policy Statement.

Please note that the NIH Loan Repayment Programs (LRPs) are a set of programs to attract and retain promising early-stage investigators in research careers by helping them to repay their student loans. Recipients of fellowship awards are encouraged to consider applying for an extramural LRP award.

Authority and Regulations

Awards are made under the authorization of Section 487 of the Public Health Service Act as amended (42 USC 288) and under Federal Regulations 42 CFR 66.

NIH Office of Extramural Research Logo
Department of Health and Human Services (HHS) - Home Page
Department of Health
and Human Services (HHS)
USA.gov - Government Made Easy
NIH... Turning Discovery Into Health®


Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.